137 related articles for article (PubMed ID: 38814372)
1. Utility of time in tight range (TITR) in evaluating metabolic control in pediatric and adult patients with type 1 diabetes in treatment with advanced hybrid closed-loop systems.
Bahillo-Curieses P; Fernández Velasco P; Pérez-López P; Vidueira Martínez AM; Nieto de la Marca MO; Díaz-Soto G
Endocrine; 2024 May; ():. PubMed ID: 38814372
[TBL] [Abstract][Full Text] [Related]
2. Assessing the feasibility of time in tight range (TITR) targets with advanced hybrid closed loop (AHCL) use in children and adolescents: A single-centre real-world study.
Eviz E; Killi NE; Karakus KE; Can E; Gokce T; Yesiltepe Mutlu G; Hatun S
Diabet Med; 2024 Apr; ():e15333. PubMed ID: 38671595
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of Continuous Glucose Monitoring-Measured Time-in-Range 70-180 mg/dL Versus Time-in-Tight-Range 70-140 mg/dL.
Beck RW; Raghinaru D; Calhoun P; Bergenstal RM
Diabetes Technol Ther; 2024 Mar; 26(3):151-155. PubMed ID: 37870460
[No Abstract] [Full Text] [Related]
4. Time In Tight Range in children and adolescents with type 1 diabetes: A cross-sectional observational single centre study evaluating efficacy of new advanced technologies.
Schiaffini R; Lumaca A; Martino M; Rapini N; Deodati A; Amodeo ME; Ciampalini P; Matteoli MC; Pampanini V; Cianfarani S
Diabetes Metab Res Rev; 2024 Jul; 40(5):e3826. PubMed ID: 38824455
[TBL] [Abstract][Full Text] [Related]
5. Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes.
Dunn TC; Ajjan RA; Bergenstal RM; Xu Y
Diabetes Technol Ther; 2024 Mar; 26(3):203-210. PubMed ID: 38444315
[TBL] [Abstract][Full Text] [Related]
6. Safety and Glycemic Outcomes During the MiniMed
Pihoker C; Shulman DI; Forlenza GP; Kaiserman KB; Sherr JL; Thrasher JR; Buckingham BA; Kipnes MS; Bode BW; Carlson AL; Lee SW; Latif K; Liljenquist DR; Slover RH; Dai Z; Niu F; Shin J; Jonkers RAM; Roy A; Grosman B; Vella M; Cordero TL; McVean J; Rhinehart AS; Vigersky RA;
Diabetes Technol Ther; 2023 Nov; 25(11):755-764. PubMed ID: 37782145
[No Abstract] [Full Text] [Related]
7. Aiming for the Best Glycemic Control Beyond Time in Range: Time in Tight Range as a New Continuous Glucose Monitoring Metric in Children and Adolescents with Type 1 Diabetes Using Different Treatment Modalities.
Passanisi S; Piona C; Salzano G; Marigliano M; Bombaci B; Morandi A; Alibrandi A; Maffeis C; Lombardo F
Diabetes Technol Ther; 2024 Mar; 26(3):161-166. PubMed ID: 37902743
[No Abstract] [Full Text] [Related]
8. Time in Range, Time in Tight Range, and Average Glucose Relationships Are Modulated by Glycemic Variability: Identification of a Glucose Distribution Model Connecting Glycemic Parameters Using Real-World Data.
Xu Y; Dunn TC; Bergenstal RM; Cheng A; Dabiri Y; Ajjan RA
Diabetes Technol Ther; 2024 Feb; ():. PubMed ID: 38315505
[No Abstract] [Full Text] [Related]
9. Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study.
Seget S; Jarosz-Chobot P; Ochab A; Polanska J; Rusak E; Witoszek P; Chobot A
Front Endocrinol (Lausanne); 2022; 13():1036808. PubMed ID: 36303875
[TBL] [Abstract][Full Text] [Related]
10. MiniMed 780G™ advanced hybrid closed-loop system performance in Egyptian patients with type 1 diabetes across different age groups: evidence from real-world users.
Elbarbary NS; Ismail EAR
Diabetol Metab Syndr; 2023 Oct; 15(1):205. PubMed ID: 37845757
[TBL] [Abstract][Full Text] [Related]
11. Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users.
Silva JD; Lepore G; Battelino T; Arrieta A; Castañeda J; Grossman B; Shin J; Cohen O
Diabetes Technol Ther; 2022 Feb; 24(2):113-119. PubMed ID: 34524003
[No Abstract] [Full Text] [Related]
12. One-year follow-up comparison of two hybrid closed-loop systems in Italian children and adults with type 1 diabetes.
Bassi M; Patti L; Silvestrini I; Strati MF; Ponzano M; Minuto N; Maggi D
Front Endocrinol (Lausanne); 2023; 14():1099024. PubMed ID: 36777356
[TBL] [Abstract][Full Text] [Related]
13. Predictors of time in target glucose range in real-world users of the MiniMed 780G system.
Castañeda J; Mathieu C; Aanstoot HJ; Arrieta A; Da Silva J; Shin J; Cohen O
Diabetes Obes Metab; 2022 Nov; 24(11):2212-2221. PubMed ID: 35791621
[TBL] [Abstract][Full Text] [Related]
14. Glycemic control metrics in a cohort of hospitalized patients with type 1 diabetes using hybrid closed-loop and advanced hybrid closed-loop systems.
Gómez Medina AM; Henao-Carrillo DC; Yepes C; Silva J; Gómez González JA; Cortes D; Robledo S; Mejía G; Rondon M
Diabetes Res Clin Pract; 2023 Oct; 204():110897. PubMed ID: 37678728
[TBL] [Abstract][Full Text] [Related]
15. Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI).
Petrovski G; Al Khalaf F; Campbell J; Day E; Almajaly D; Hussain K; Pasha M; Umer F; Hamdan M; Khalifa A
BMC Endocr Disord; 2022 Mar; 22(1):80. PubMed ID: 35351095
[TBL] [Abstract][Full Text] [Related]
16. Long-term effectiveness of advanced hybrid closed loop in children and adolescents with type 1 diabetes.
Piccini B; Pessina B; Casalini E; Lenzi L; Toni S
Pediatr Diabetes; 2022 Dec; 23(8):1647-1655. PubMed ID: 36317539
[TBL] [Abstract][Full Text] [Related]
17. The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study.
De Meulemeester J; Charleer S; Visser MM; De Block C; Mathieu C; Gillard P
Diabetologia; 2024 May; ():. PubMed ID: 38787436
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two advanced hybrid closed loop in a pediatric population with type 1 diabetes: a real-life observational study.
Schiaffini R; Deodati A; Nicoletti MC; Carducci C; Ciampalini P; Lorubbio A; Matteoli MC; Pampanini V; Patera IP; Rapini N; Cianfarani S
Acta Diabetol; 2022 Jul; 59(7):959-964. PubMed ID: 35451679
[TBL] [Abstract][Full Text] [Related]
19. Impact of an advanced hybrid closed-loop system on glycemic control throughout the menstrual cycle in women with type 1 diabetes prone to hypoglycemia.
Mesa A; Solà C; Vinagre I; Roca D; Granados M; Pueyo I; Cabré C; Conget I; Giménez M
Diabetes Technol Ther; 2024 Mar; ():. PubMed ID: 38441905
[TBL] [Abstract][Full Text] [Related]
20. Characteristics Associated With Elevated Time Below Range in Elderly Patients With Type 1 Diabetes Using an Automated Insulin Delivery System.
Gómez Medina AM; Parra Prieto DA; Henao Carrillo DC; Gómez CM; Muñoz Velandia OM; Caicedo S; Kerguelen Villadiego AL; Rodríguez Hortúa LM; Lucero Pantoja OD; Uribe Valencia M; García Guete MM; Robledo Gómez S; Rondón Sepúlveda M
J Diabetes Sci Technol; 2024 Mar; ():19322968241232659. PubMed ID: 38506435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
